Belvedere Trading’s Sotera Health SHC Stock Holding History

Belvedere Trading’s Portfolio SHC Stock Details SHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,718	Closed	-$45.4K	–	1371
2022 Q4	$22.6K	Buy	+2,718	New	+$20.3K	﹤0.01%	806

Other funds holding SHC

Warburg Pincus New York $343M AUM 18.86% 1-Year Est. Return

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

MIG Capital Newport Beach, California $589M AUM 25.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Belvedere Trading's SHC Position: Q1 2023 in Review

Belvedere Trading sold out of Sotera Health (SHC) in Q1 2023, closing a stake of 2,718 shares — an estimated $45.4K sold.

Belvedere Trading first reported a position in SHC in Q4 2022 and held it in 1 quarter. The position peaked at $22.6K in Q4 2022. 182 funds tracked by Wall St. Rank hold SHC as of Q1 2023.

Belvedere Trading reported no remaining Sotera Health position as of Q1 2023 after selling out during the quarter.
Belvedere Trading sold 2,718 Sotera Health shares in Q1 2023, an estimated $45.4K.
Belvedere Trading first reported a position in Sotera Health in Q4 2022 and held it in 1 quarter.
Belvedere Trading's Sotera Health position peaked at $22.6K in Q4 2022.
182 funds tracked by Wall St. Rank held Sotera Health as of Q1 2023.

Based on Belvedere Trading's 13F filing for Q1 2023, filed 15 May 2023.